JANX Competitors & Alternatives
Compare Janux Therapeutics Inc with similar stocks in the same industry
Biotechnology
JANX
Main Stock$15.54
Tradestie Score
60
Market Cap
$1.42B
Revenue Growth
21.8%
Analyst Upside
+139.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OCS
Oculis Holding AG Ordinary shares
|
$14.12
|
$910.64M | - | 59 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$29.00
|
$906.29M | - | 59 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$38.40
|
$903.54M | - | 51 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$85.21
|
$900.91M | - | 60 | Compare |
|
GERN
Geron Corp
|
$1.36
|
$899.60M | - | 53 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$63.42
|
$894.30M | - | 57 | Compare |
|
EYPT
EyePoint Pharmaceuticals, Inc. Common Stock
|
$13.98
|
$890.20M | - | 56 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$29.46
|
$887.30M | - | 60 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.87
|
$879.90M | 5.7 | 56 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$11.20
|
$871.90M | - | 57 | Compare |
More JANX Analysis
Data updated: Jul 02, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry